Your browser doesn't support javascript.
loading
Randomised, double-blind, placebo-controlled, parallel-group, multicentric, phase IIA clinical trial for evaluating the safety, tolerability, and therapeutic efficacy of daily oral administration of NFX88 to treat neuropathic pain in individuals with spinal cord injury.
Escribá, Pablo V; Gil-Agudo, Ángel M; Vidal Samsó, Joan; Sánchez-Raya, Judith; Salvador-de la Barrera, Sebastián; Soto-León, Vanesa; León-Álvarez, Natacha; Méndez Ferrer, Bosco; Membrilla-Mesa, Miguel David; Redondo Galán, Carolina; Benito-Penalva, Jesús; Montoto-Marqués, Antonio; Medel Rebollo, Javier; Palazón García, Ramiro; Gutiérrez Henares, Francisco; Miralles, Marc; Torres, Manuel; Nieto-Librero, Ana B; García Marco, David; Gómez, Carmela; Jimeno, David; Oliviero, Antonio.
Affiliation
  • Escribá PV; Universidad Islas Baleares, Palma, Islas Baleares, Spain.
  • Gil-Agudo ÁM; Hospital Nacional de Parapléjicos, SESCAM, Toledo, Spain.
  • Vidal Samsó J; Fundación Institut Guttmann, Institut Universitari de Neurorehabilitació adscrit a la Universitat Autònoma de Barcelona, 08916, Badalona, Spain.
  • Sánchez-Raya J; Hospital Campus Vall d'Hebron, Barcelona, Spain.
  • Salvador-de la Barrera S; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
  • Soto-León V; Hospital Nacional de Parapléjicos, SESCAM, Toledo, Spain.
  • León-Álvarez N; Hospital Los Madroños, Brunete, Madrid, Spain.
  • Méndez Ferrer B; Hospital Universitario Virgen del Rocio, Sevilla, Spain.
  • Membrilla-Mesa MD; Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain.
  • Redondo Galán C; Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Benito-Penalva J; Hospital Nacional de Parapléjicos, SESCAM, Toledo, Spain.
  • Montoto-Marqués A; Fundación Institut Guttmann, Institut Universitari de Neurorehabilitació adscrit a la Universitat Autònoma de Barcelona, 08916, Badalona, Spain.
  • Medel Rebollo J; Complejo Hospitalario Universitario A Coruña, A Coruña, Spain.
  • Palazón García R; Hospital Campus Vall d'Hebron, Barcelona, Spain.
  • Gutiérrez Henares F; Hospital Nacional de Parapléjicos, SESCAM, Toledo, Spain.
  • Miralles M; Hospital Nacional de Parapléjicos, SESCAM, Toledo, Spain.
  • Torres M; Universidad Islas Baleares, Palma, Islas Baleares, Spain.
  • Nieto-Librero AB; Universidad Islas Baleares, Palma, Islas Baleares, Spain.
  • García Marco D; Departamento de Estadística, Universidad de Salamanca, Salamanca, Spain.
  • Gómez C; Instituto de Investigación Biomédica de Salamanca, Salamanca, Spain.
  • Jimeno D; Hospital Nacional de Parapléjicos, SESCAM, Toledo, Spain.
  • Oliviero A; Neurofixpharma SA, Salamanca, Spain.
Spinal Cord ; 62(8): 454-467, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38898145
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Spinal Cord Injuries / Neuralgia Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Spinal Cord Journal subject: NEUROLOGIA Year: 2024 Type: Article Affiliation country: Spain
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Spinal Cord Injuries / Neuralgia Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Spinal Cord Journal subject: NEUROLOGIA Year: 2024 Type: Article Affiliation country: Spain